Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome


Efe C., Ozaslan E., KAV T. , Purnak T. , Shorbagi A., ÖZKAYAR Ö. , ...Daha Fazla

AUTOIMMUNITY REVIEWS, cilt.11, sa.5, ss.330-334, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 11 Konu: 5
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1016/j.autrev.2011.09.006
  • Dergi Adı: AUTOIMMUNITY REVIEWS
  • Sayfa Sayıları: ss.330-334

Özet

Background and aim: The aim of the present study was to assess the efficacy and tolerability of budesonide as an alternative first line treatment option for autoimmune hepatitis (AIH) and the overlap syndrome.